Literature DB >> 11739128

Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research.

K R Minter1, M T Gladwin.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11739128     DOI: 10.1164/ajrccm.164.11.2104101

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  23 in total

Review 1.  The paradox of the neutrophil's role in tissue injury.

Authors:  George B Segel; Marc W Halterman; Marshall A Lichtman
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

2.  Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.

Authors:  Robyn J Barst; Kamal K Mubarak; Roberto F Machado; Kenneth I Ataga; Raymond L Benza; Oswaldo Castro; Robert Naeije; Namita Sood; Paul S Swerdlow; Mariana Hildesheim; Mark T Gladwin
Journal:  Br J Haematol       Date:  2010-02-17       Impact factor: 6.998

Review 3.  Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment.

Authors:  Raymond L Benza
Journal:  Lung       Date:  2008-05-10       Impact factor: 2.584

4.  Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea.

Authors:  Anthony J Grady; Jane S Hankins; Brent Haberman; Robert Schoumacher; Rose Mary Stocks
Journal:  Sleep Breath       Date:  2017-01-11       Impact factor: 2.816

5.  An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Authors:  Elizabeth S Klings; Roberto F Machado; Robyn J Barst; Claudia R Morris; Kamal K Mubarak; Victor R Gordeuk; Gregory J Kato; Kenneth I Ataga; J Simon Gibbs; Oswaldo Castro; Erika B Rosenzweig; Namita Sood; Lewis Hsu; Kevin C Wilson; Marilyn J Telen; Laura M Decastro; Lakshmanan Krishnamurti; Martin H Steinberg; David B Badesch; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

6.  Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report.

Authors:  Serena Dovey; Lakshmanan Krishnamurti; Joseph Sanfilippo; Sriya Gunawardena; Patricia Mclendon; Mary Campbell; Sandra Alway; Brenda Efymow; Clarisa Gracia
Journal:  J Assist Reprod Genet       Date:  2012-01-05       Impact factor: 3.412

Review 7.  Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series).

Authors:  Bradley A Maron; Roberto F Machado; Larissa Shimoda
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

8.  Upper airway lymphoid tissue size in children with sickle cell disease.

Authors:  Temima Strauss; Sanghun Sin; Carole L Marcus; Thornton B A Mason; Joseph M McDonough; Julian L Allen; Jason B Caboot; Cheryl Y Bowdre; Abbas F Jawad; Kim Smith-Whitley; Kwaku Ohene-Frempong; Allan I Pack; Raanan Arens
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

9.  Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.

Authors:  Anastasia Anthi; Roberto F Machado; Maria L Jison; Angelo M Taveira-Dasilva; Lewis J Rubin; Lori Hunter; Christian J Hunter; Wynona Coles; James Nichols; Nilo A Avila; Vandana Sachdev; Clara C Chen; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2007-03-22       Impact factor: 21.405

Review 10.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.